A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 243 participants.
Also called NCT04750577
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 243 participants
- Sponsor
- Registry
-
NCT04750577 -
2020-002929-28
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Canada, China, Denmark, Hong Kong SAR China, Japan, Malaysia, Mexico, Netherlands, New Zealand, Poland, Portugal, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04750577. Randomized; quadruple masking; primary purpose treatment. Start 2021-04-27 (actual); primary completion 2022-11-30 (actual). Results posted on 2024-07-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
- Condition
- Diabetic Nephropathies
- Intervention (Drug)
- Placebo matching BI 685509
- Intervention (Drug)
- BI 685509
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct04750577- Content hash
ce45ccd0c6d1373541cb5e2ec533ed99d3428c1eb65777449b88efa50439c444